Bausch Health Companies Inc. (NYSE:BHC) Q3 2024 Earnings Call Transcript
Operator: Greetings. Welcome to the Bausch Health Third Quarter 2024 Earnings Call. [Operator Instructions]. Please note this conference is being recorded.
Bausch Health Companies Inc. (BHC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Icahn Capital LP Carl Icahn | 34,721,118 | $242,006,192 | 2.23% | |
| 2. | Paulson & Co John Paulson | 26,439,035 | $184,280,074 | 13.62% | |
| 3. | GoldenTree Asset Management Steven Tananbaum | 22,437,028 | $156,386,085 | -19% | 12.97% |
| 4. | Hudson Bay Capital Management Sander Gerber | 11,500,000 | $80,155,000 | -3% | 0.37% |
| 5. | Citadel Investment Group Ken Griffin | 7,077,306 | $49,328,823 | +84% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.17 | 10,000 | Director | 10,000 | 2021-11-30 | Filing | |
| $24.24 | 50,000 | Director | 60,780 | 2021-11-30 | Filing | |
| $25.94 | 1,400 | Director | 38,647 | 2021-08-05 | Filing | |
| $25.01 | 10,000 | Director | 317,109 | 2021-08-04 | Filing | |
| $19.24 | 948,353 | Director, Other | 17,931,594 | 2020-06-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.21 | 13,370 | Officer | 435,198 | 2024-09-06 | Filing | |
| $9.80 | 133 | Officer | 499,905 | 2024-03-04 | Filing | |
| $9.80 | 1,561 | Officer | 500,038 | 2024-03-04 | Filing | |
| $9.80 | 199 | Officer | 501,599 | 2024-03-04 | Filing | |
| $9.80 | 4,420 | Officer | 501,798 | 2024-03-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,801,343 | $126,726,909 | 0.05% | |
| 2. | 15,649,539 | $121,751,074 | 0.19% | |
| 3. | 13,296,000 | $106,633,920 | 0.28% | |
| 4. | 13,000,000 | $104,260,000 | 0.35% | |
| 5. | 11,743,558 | $94,183,000 | 0.02% |
News See All
Carl Icahn Stock Portfolio: 7 Best Stocks to Buy
Carl Icahn is a force to reckon with, having made a name and billions of dollars on questioning decisions and strategies of corporate leaders on Wall Street for decades.
Billionaire Carl Icahn's Top 10 Stocks
One would expect legendary investor Carl Icahn to go slow and cherish his extraordinary and successful career on Wall Street.
Bausch Health Companies Inc. (NYSE:BHC) Q2 2024 Earnings Call Transcript
Bausch Health Companies Inc. (NYSE:BHC) Q2 2024 Earnings Call Transcript August 1, 2024Bausch Health Companies Inc. misses on earnings expectations.
Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
Bausch Health Companies Inc. misses on earnings expectations. Reported EPS is $0.59 EPS, expectations were $0.75. Bausch Health Companies Inc.
5 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the five best low price pharma stocks to invest in.
10 Best Healthcare Stocks to Buy Under $20
In this article, we will be taking a look at the 10 best healthcare stocks to buy under $20.
The Enduring Losses Incurred by Carl Icahn's 10 Activist Targets over the Long Term
In this article, we discuss the losses incurred by Carl Icahn's 10 activist targets over the long term.
5 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 5 best medical stocks to buy under $10.
Bausch Health Companies Inc. (NYSE:BHC) Q4 2023 Earnings Call Transcript
Bausch Health Companies Inc. beats earnings expectations. Reported EPS is $1.15, expectations were $1.01.
Billionaire Hedge Funds
